- Home
- IGIC vs CVAC Comparison
IGIC vs CVAC Comparison
Compare IGIC & CVAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IGIC
- CVAC
- Stock Information
- Founded
- IGIC 2001
- CVAC 2000
- Country
- IGIC Jordan
- CVAC Germany
- Employees
- IGIC N/A
- CVAC N/A
- Industry
- IGIC Property-Casualty Insurers
- CVAC Biotechnology: Pharmaceutical Preparations
- Sector
- IGIC Finance
- CVAC Health Care
- Exchange
- IGIC Nasdaq
- CVAC Nasdaq
- Market Cap
- IGIC 1.0B
- CVAC 1.2B
- IPO Year
- IGIC N/A
- CVAC 2020
- Fundamental
- Price
- IGIC $24.18
- CVAC $5.39
- Analyst Decision
- IGIC Buy
- CVAC Hold
- Analyst Count
- IGIC 2
- CVAC 3
- Target Price
- IGIC $31.50
- CVAC $6.83
- AVG Volume (30 Days)
- IGIC 71.3K
- CVAC 632.4K
- Earning Date
- IGIC 11-04-2025
- CVAC 08-15-2025
- Dividend Yield
- IGIC 0.41%
- CVAC N/A
- EPS Growth
- IGIC 11.00
- CVAC N/A
- EPS
- IGIC 2.79
- CVAC 1.01
- Revenue
- IGIC $535,109,000.00
- CVAC $599,540,810.00
- Revenue This Year
- IGIC $6.05
- CVAC N/A
- Revenue Next Year
- IGIC $7.01
- CVAC $24.04
- P/E Ratio
- IGIC $8.66
- CVAC $5.36
- Revenue Growth
- IGIC 9.99
- CVAC 675.15
- 52 Week Low
- IGIC $17.06
- CVAC $2.37
- 52 Week High
- IGIC $27.76
- CVAC $5.72
- Technical
- Relative Strength Index (RSI)
- IGIC 50.36
- CVAC 49.09
- Support Level
- IGIC $24.15
- CVAC $5.33
- Resistance Level
- IGIC $24.45
- CVAC $5.48
- Average True Range (ATR)
- IGIC 0.53
- CVAC 0.04
- MACD
- IGIC -0.05
- CVAC -0.01
- Stochastic Oscillator
- IGIC 21.45
- CVAC 38.89
About IGIC International General Insurance Holdings Ltd.
International General Insurance Holdings Ltd is an international specialist commercial insurer and a reinsurer, underwriting a diverse portfolio of specialty lines. The company operates in a portfolio of Energy, Property, Construction, Engineering, Ports and terminals, Financial Institutions, General Aviation, Professional Indemnity, Casualty, Directors and Officers, Political Violence, Forestry, and Treaty Reinsurance. Its operating segment includes Specialty Longtail; Specialty Short tail and Reinsurance.
About CVAC CureVac N.V.
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.